Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS) Français
Following this important milestone, Cosentyx has been listed in Québec
MONTRÉAL, July 10, 2025 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the successful conclusion of negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) on the public reimbursement of Cosentyx (secukinumab) for the treatment of adults with moderate to severe hidradenitis suppurativa (HS), a chronic, painful and often debilitating inflammatory skin condition. 1
Following the completion of these negotiations, Cosentyx has been listed in Québec, making it the first province to provide public reimbursement for Cosentyx in HS. Novartis remains committed to ongoing collaboration with provincial public drug programs across Canada to enable timely access and reimbursement for eligible patients nationwide.
"Too often, people living with HS feel like their condition is invisible within the healthcare system," said Latoya Palmer, Founder of Hidradenitis and Me Support Group. "As someone living with HS, it gives me hope to see this step forward. It feels validating and shows people like me that there is a path toward better support for those who need it most."
"For people living with moderate to severe HS, the condition can have a profound impact on daily life - not only due to physical symptoms, but also the emotional toll it can take," said Dr. Susan Poelman, Canadian and U.S. Board-Certified Dermatologist. "The conclusion of pCPA negotiations for Cosentyx is a promising step that could help expand possibilities for patients who have historically had limited treatment options."
"Concluding pCPA negotiations for Cosentyx in HS is an important step toward improving access to a therapy grounded in strong science and real patient need," said Mark Vineis, Country President, Novartis Pharmaceuticals Canada Inc. "At Novartis, we are committed to continuing to work with stakeholders across the healthcare system to help ensure eligible patients with HS have timely public access to innovative treatment options."
About Cosentyx ® (secukinumab)
Cosentyx is the first and only fully human biologic that directly inhibits interleukin-17A, an important cytokine involved in many inflammatory diseases. 2,3 Cosentyx is a proven medicine and has been studied clinically for more than 14 years. The medicine is backed by robust evidence, including 5 years of clinical data in adults supporting long-term safety and efficacy across moderate to severe plaque psoriasis (PsO), Axial spondyloarthritis (axSpA) and juvenile idiopathic arthritis (JIA). 4,5,6,7,8,9 These data strengthen the position of Cosentyx as a treatment across moderate to severe PsO (adult and pediatric), PsA, HS, axial spondyloarthritis (axSpA), and juvenile idiopathic arthritis (JIA), including enthesitis-related arthritis and juvenile PsA. More than 1 million patients have been treated with Cosentyx worldwide since its launch in 2015.
About Novartis
Novartis is a focused innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide. Reimagine medicine with us.
In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 600 people to serve the evolving needs of patients and the healthcare system and invests over $30 million in R&D yearly in the country. For more information visit www.novartis.ca.
FA-11466794E
SOURCE Novartis Pharmaceuticals Canada Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Observer
an hour ago
- National Observer
Canada beyond Trump: Climate rages on as our greatest challenge
Long after the current US government has gone, the climate crisis will remain the greatest existential threat of our time. While it's no surprise the recent Canadian federal election was dominated by the immediacy of unprecedented US threats against us, the environment is critically intertwined with every major issue, ranging from Canadian sovereignty to the economy, jobs, housing and health. Whether we're talking about it or not, the climate crisis continues to escalate, affecting nearly every facet of our lives. Canadians and our new federal government must recognize that strong climate policies now will ultimately make or break our future, and that of our children. The climate crisis shortens lifespans, costing both lives and dollars. Health experts worldwide, ranging from the World Health Organization to the Canadian Public Health Association, recognize climate change as the greatest health challenge of the 21st century. Burning fossil fuels, including the potent so-called 'natural' gas, generates both carbon pollution that causes climate change and toxic air pollution associated with widespread human health harms. Air pollution is linked to roughly one in seven premature deaths in Canada, while burning fossil fuels is linked to one in five deaths worldwide. Climate change contributes to health harms through extreme weather and heat, food insecurity, proliferating infectious diseases and more. Both climate change and air pollution are associated with severe mental health harms, including depression and suicide, especially impacting our youth. Environmental impacts increase the burden of diseases requiring care, while also damaging our health care systems at massive financial cost. Together, these risks are making our health system entirely unsustainable. Climate change is already slowing Canada's economy, with costs in 2025 estimated at $25 billion. This cuts Canada's gross domestic product (GDP) growth in half, hurting every household in the country. As far back as 2016, the economic cost of premature deaths associated with air pollution across Canada was estimated at $114 billion annually. Over the next few decades, climate change is expected to trigger up to an additional $100 billion per year or more in health-related costs alone due to the impacts of heat, ground-level ozone, infectious diseases and more. Policies that get us off fossil fuels and fight climate change would effectively lower those costs, reduce illness and relieve pressure on the already overstretched Canadian health system, while keeping pace with global decarbonization trends. We would all benefit. Slashing billions from government services to fund massive military spending, while building pipelines and attempting to keep a fossil-fuel-based economy on life support, are not the way forward. They are simply archaic. Every dollar invested in climate action pays back approximately two dollars in health care savings alone — a doubled return on investment that more than pays for itself. Pollution pricing is one of the most effective — and yet least expensive — tools to slash both air pollution and carbon pollution that threaten our livable future. In the lead up to the federal election, we lost consumer-facing pollution pricing, which ranked as the fourth-most effective emissions-reduction policy in Canada. However, the still-standing industrial pollution pricing is Canada's single most important policy to drive down emissions by making the largest industrial polluters pay. The federal government must respect its election promise to protect industrial pollution pricing. We can't afford to drop the most powerful tool we have to protect our future. A strong Canadian climate policy will save lives and improve health, while keeping the cost of our healthcare system sustainable to help stabilize our economy. A current nationwide campaign calling for federal climate action and protection of industrial pollution pricing has already been endorsed by over 85 organizations and counting, including both the Canadian Medical Association and the Canadian Public Health Association. Recent polling shows 73 per cent of Canadians agree that walking away from pollution pricing betrays our kids and the majority are open to voting for a party defending pollution pricing. This mirrors results of a global study of 130,000 people, revealing 89 per cent want increased political action on climate worldwide. Climate change must be treated like the public health emergency that it is. We must hold the federal government accountable to lead Canada at this pivotal moment with sustainable, forward-thinking policies incorporating urgent climate action. Slashing polluting emissions will yield massive health and economic co-benefits, while keeping us competitive on the global stage. We are the final generation with the opportunity to choose a liveable future for ourselves and for our children. Dr. Mili Roy is a practicing physician and surgeon in the Greater Toronto area. She serves as Ontario Regional co-Chair of the Canadian Association of Physicians for the Environment (CAPE).
Global News
8 hours ago
- Global News
Multiple Metro Vancouver beaches closed due to elevated E. coli levels
See more sharing options Send this page to someone via email Share this item on Twitter Share this item via WhatsApp Share this item on Facebook Vancouver Coastal Health has closed multiple Metro Vancouver beaches to swimming due to elevated E. coli levels. The advisories include English Bay, Kitsilano Beach, Second Beach, Sunset Beach and Third Beach in Vancouver, along with Trout Lake. On the North Shore, Dundarave and Lions Bay Beach are also closed. 0:00 Health Matters: Vancouver water study Under Canadian recreational water quality guidelines, beach closures are possible when officials find a single sample that exceeds 400 E. coli per 100 ml. of water, or a five-sample average exceeding 200 per 100 ml. Story continues below advertisement Sampling found E. coli levels in some cases at more than four times the guidelines. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Investigations are also underway at seven other beaches, including Jericho Beach and Ambleside Beach due to higher-than-expected sample results, though swimming isn't restricted at this time. E. coli is the same bacteria that can be found on vegetables or in beef. It is of particular concern for vulnerable populations, such as kids and seniors. A major contributor to E. coli in the water comes from fecal matter, both human and animal.
Winnipeg Free Press
12 hours ago
- Winnipeg Free Press
B.C. limits sales of two more diabetes drugs amid off-label use for weight loss
VICTORIA – British Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight loss and preserve supply for people who are diabetic. The limits on sales of Type 2 diabetes drugs tirzepatide and dulaglutide come after a 2023 regulation limited sales of semaglutide, which is sold under the band name Ozempic. The rules mean B.C. pharmacists will not be able to sell the drugs to people who are not citizens or permanent residents of Canada and are not at the pharmacy in person. Health Minister Josie Osborne says the drugs' use for weight loss is driving shortages in several countries, including the United States. She says the province is working to ensure people living with diabetes have access to the medications they need, although non-residents and foreign citizens with a valid Canadian prescription can still buy them in person. Tirzepatide and dulaglutide are commonly sold under the brand names Mounjaro and Trulicity. Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. The ministry says the College of Pharmacists of B.C. is responsible for ensuring that college registrants comply with the regulation. This report by The Canadian Press was first published July 17, 2025.
